Abstract
Treatment with cardiac implantable electronic devices is not free from complications, including infections, which not only influence long term outcome, but also significantly impact healthcare budget. The costs of management of cardiac device related infections ranged from several to tens or even hundreds of thousands euro. A risk of infection varies from 0,5 to 5,0 and more percent and depends on: type of procedure, complexity of system, number of previous procedures performed, renal failure, immunosuppression, heart failure, malignancies, oral anticoagulant treatment, use of temporary pacing before procedure. Based on PADIT trial results infection risk score was established based on 5 parameters (age, type of procedure, renal failure, immunodeficiency, number of previous procedure). This score allows to define population of patients with low, intermediate and high risk to develop infection. In high risk group, despite standard preparation to the procedure, some additional tools should be considered to reduce infection rate. It relates mainly, but is not limited to, device exchange, revisions, up-grades of cardiac resynchronization systems.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
